Financial results - ELITE PHARMA SRL

Financial Summary - Elite Pharma Srl
Unique identification code: 11166158
Registration number: J04/1007/1998
Nace: 7022
Sales - Ron
11.740
Net Profit - Ron
3.632
Employees
Open Account
Company Elite Pharma Srl with Fiscal Code 11166158 recorded a turnover of 2024 of 11.740, with a net profit of 3.632 and having an average number of employees of - . The company operates in the field of Activitati de consultanta pentru afaceri si management having the NACE code 7022.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Elite Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 6.097 2.227 2.207 5.130 9.096 8.911 9.248 10.846 11.447 11.740
Total Income - EUR 6.097 2.227 2.207 5.144 9.096 8.911 11.224 11.819 14.101 12.142
Total Expenses - EUR 17.308 12.010 7.796 4.750 6.186 4.276 8.866 9.632 12.437 7.875
Gross Profit/Loss - EUR -11.212 -9.783 -5.589 394 2.910 4.635 2.358 2.188 1.664 4.267
Net Profit/Loss - EUR -11.394 -9.850 -5.656 239 2.637 4.367 2.114 1.885 1.367 3.632
Employees 0 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 3.1%, from 11.447 euro in the year 2023, to 11.740 euro in 2024. The Net Profit increased by 2.272 euro, from 1.367 euro in 2023, to 3.632 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Elite Pharma Srl

Rating financiar

Financial Rating -
ELITE PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Elite Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Elite Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Elite Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Elite Pharma Srl - CUI 11166158

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 110.868 108.038 102.094 99.180 93.161 80.681 78.920 86.046 84.830 89.477
Current Assets 16.859 4.965 4.361 5.804 3.159 6.171 5.826 3.093 5.568 5.077
Inventories 181 0 0 968 0 0 0 0 0 0
Receivables 3.988 4.168 3.775 3.137 1.767 926 91 312 195 194
Cash 12.690 797 586 1.699 1.391 5.245 5.736 2.781 5.373 4.883
Shareholders Funds 116.994 105.951 95.482 93.969 91.422 84.234 84.480 84.935 86.045 89.196
Social Capital 67 67 66 64 63 62 61 61 61 60
Debts 10.732 7.052 10.972 11.015 4.899 2.618 266 4.203 4.353 5.358
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7022 - 7022"
CAEN Financial Year 7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.077 euro in 2024 which includes Inventories of 0 euro, Receivables of 194 euro and cash availability of 4.883 euro.
The company's Equity was valued at 89.196 euro, while total Liabilities amounted to 5.358 euro. Equity increased by 3.632 euro, from 86.045 euro in 2023, to 89.196 in 2024.

Risk Reports Prices

Reviews - Elite Pharma Srl

Comments - Elite Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.